I
n November 2013, USA Today, 1 WebMD 2 and other news outlets reported the results of a study presented at an American Heart Association annual meeting in Dallas. The study highlighted common symptoms that preceded heart attacks in 567 men aged 35 to 65 years, based on retrospective chart review. The results, though not unexpected, seemed to gain traction because of the recent death of a well-known actor (James Gandolfini, The Sopranos) from a sudden myocardial infarction. To quote the USA Today synopsis of the study:
• 53 % had symptoms prior to the cardiac arrest.
• Of those who had symptoms, 56 % had chest pain; 13 %, shortness of breath; 4 %, dizziness, fainting or heart palpitations.
• Almost 80 % of the symptoms occurred between 4 weeks and 1 hour before the sudden cardiac arrest.
• Most of the men had coronary artery disease, but only a quarter had been diagnosed.
The implication of the USA Today article was that any middle-aged man with chest pain or shortness of breath may be having a heart attack. Thus, while the overall message from the investigators (seek medical care if you [middle-aged man] are having new or troubling symptoms) may have been useful, the news reports of the study were plagued by the lack of a denominator, indicating the prevalence of these symptoms amongst the population of interest. For instance, in a cohort of 1 million middle-aged men, how many will have chest pain or shortness of breath in a month? Even if 50,000 men developed those vague symptoms, how many would subsequently have a heart attack? Certainly, not all 50,000-as the USA Today and WebMD articles seem to imply. Unintentionally, the media exaggerated and overstated the results of an associative retrospective cohort study. Improving statistical literacy would help to ameliorate these kinds of misconceptions common in the popular media, with our patients, and even among many physicians.
Statistical literacy is a core skill needed by clinicians, researchers and medical educators to accurately contextualize a study design and interpret the validity of those results. Similarly, medical journals are responsible for helping their readership become more informed about the utility and limitations of new information, by helping them to place the information in the appropriate context.
With this in mind, JGIM has launched a new collaboration with the BMJ, showcasing the BMJ Endgame series on statistics and research methodology authored by Philip Sedgwick.
Each month for the next year, JGIM Web will feature one of Dr. Sedgwick's thoughtful articles, exploring seminal issues in medical research methodology and interpretation. Each article illustrates how selection of a study design, or approach to analysis, can influence the reliability and validity of those results. We selected articles that we felt were aimed at an "intermediate" statistical level.
This BMJ Endgame series will be available on the JGIM Web (www.jgim.org), starting in March 2014, often with accompanying articles and other value-added material. We anticipate that the BMJ series will be useful to our readership in the following areas:
1. Medical educators working with their undergraduate medical education (UME)/graduate medical education (GME) learners to highlight data interpretation. 2. Clinicians wanting to better understand (and discuss with their patients) the implications of research findings for medical decisions. 3. Research fellows wanting to "brush up" on their understanding of core statistical/research concepts, as they approach their research projects. 4. Research faculty who want to help their mentees approach study design more rigorously, as a fodder for discussion during research and "work-in-progress" conferences.
The BMJ Endgame series will include the following articles: This month in JGIM print, there are other salient articles highlighting issues for medically vulnerable patients, and challenging aspects of emerging medical care. Simonds et al. 5 discuss how older American Indian patients view health care institutions, in comparison with their individual physician. Ursua et al. 6 examine problems with awareness and blood pressure control amongst Filipino immigrants. You 7 examined the cost-effectiveness of utilizing newer anticoagulants for atrial fibrillation, in relationship to warfarin, using a Markov model considering both patient "time in therapeutic range" and quality-adjusted life years.
The BMJ Endgame series is the latest in a series of initiatives by JGIM to provide our readership with the best evidence and the highest quality studies in our field. Other initiatives have included collaborating with the Annals of Internal Medicine around manuscript submission, and a series of Supplements that focus on key concepts in health services and educational research.
On behalf of the JGIM Editorial Team, we look forward to your feedback and suggestions for making JGIM Web more relevant to your needs.
